Glooko Positions Analytics Offering for Growing Glycemic Safety Requirements

According to a recent LinkedIn post from Glooko, new Centers for Medicare & Medicaid Services rules are making glycemic safety an enterprise-level quality metric for hospitals. The post highlights that severe hypoglycemia and hyperglycemia must now be reported, but suggests that simple reporting may be insufficient for improving outcomes.

The company’s LinkedIn post points to its EndoTool Analytics offering as a way to give hospitals deeper visibility into where severe glycemic events occur and how workflows influence those events. For investors, this emphasis implies potential incremental demand for advanced analytics tools in inpatient diabetes care, positioning Glooko to benefit as providers seek solutions that support earlier intervention and improved quality metrics under evolving CMS requirements.